Molecular Analysis for Therapy Choice (MATCH)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, lymphoma, and myeloma
This trial is available at multiple Sutter Locations. Please contact one of the following about Study Match EAY 131
San Francisco: ClinicalResearch@sutterhealth.org
Palo Alto/Santa Cruz: Tanya Pozniansky firstname.lastname@example.org
Solano-Vallejo Cancer Center: Stephanie Gonzales email@example.com
View study details on ClinicalTrials.gov
February 01, 2017
Investigator: Ellis C. Dillon, Ph.D.
Breast Tumor and Blood markers for Molecular Diagnosis of Breast Diseases and Monitoring of Breast Cancer Treatment and Follow-up
Investigator: Su-Ying Liang, Ph.D.